|
US5034506A
(en)
*
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5541308A
(en)
*
|
1986-11-24 |
1996-07-30 |
Gen-Probe Incorporated |
Nucleic acid probes for detection and/or quantitation of non-viral organisms
|
|
US5766847A
(en)
*
|
1988-10-11 |
1998-06-16 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Process for analyzing length polymorphisms in DNA regions
|
|
DE3834636A1
(de)
|
1988-10-11 |
1990-04-19 |
Max Planck Gesellschaft |
Verfahren zur analyse von laengenpolymorphismen in dna-bereichen
|
|
US6867195B1
(en)
*
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
|
US5608046A
(en)
*
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
|
FR2675803B1
(fr)
*
|
1991-04-25 |
1996-09-06 |
Genset Sa |
Oligonucleotides fermes, antisens et sens et leurs applications.
|
|
AU659482B2
(en)
|
1991-06-28 |
1995-05-18 |
Massachusetts Institute Of Technology |
Localized oligonucleotide therapy
|
|
CA2082411A1
(en)
|
1991-06-28 |
1992-12-29 |
Robert D. Rosenberg |
Localized oligonucleotide therapy
|
|
US6200747B1
(en)
*
|
1992-01-28 |
2001-03-13 |
North Shore University Hospital Research Corp. |
Method and kits for detection of fragile X specific, GC-rich DNA sequences
|
|
US5869252A
(en)
*
|
1992-03-31 |
1999-02-09 |
Abbott Laboratories |
Method of multiplex ligase chain reaction
|
|
US5418139A
(en)
*
|
1993-02-10 |
1995-05-23 |
University Of Iowa Research Foundation |
Method for screening for cardiomyopathy
|
|
CA2116280A1
(en)
|
1993-03-05 |
1994-09-06 |
Marcy E. Macdonald |
Huntingtin dna, protein and uses thereof
|
|
US5741645A
(en)
*
|
1993-06-29 |
1998-04-21 |
Regents Of The University Of Minnesota |
Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
|
|
US5627263A
(en)
*
|
1993-11-24 |
1997-05-06 |
La Jolla Cancer Research Foundation |
Integrin-binding peptides
|
|
DE4342605A1
(de)
|
1993-12-14 |
1995-06-22 |
Buna Gmbh |
Funktionalisierte Olefinhomo- und -copolymere
|
|
US5962332A
(en)
*
|
1994-03-17 |
1999-10-05 |
University Of Massachusetts |
Detection of trinucleotide repeats by in situ hybridization
|
|
AU2360195A
(en)
|
1994-05-05 |
1995-11-29 |
Beckman Instruments, Inc. |
Oligonucleotide repeat arrays
|
|
US5968909A
(en)
*
|
1995-08-04 |
1999-10-19 |
Hybridon, Inc. |
Method of modulating gene expression with reduced immunostimulatory response
|
|
US5854223A
(en)
|
1995-10-06 |
1998-12-29 |
The Trustees Of Columbia University In The City Of New York |
S-DC28 as an antirestenosis agent after balloon injury
|
|
US6300060B1
(en)
*
|
1995-11-09 |
2001-10-09 |
Dana-Farber Cancer Institute, Inc. |
Method for predicting the risk of prostate cancer morbidity and mortality
|
|
DK0882061T3
(da)
|
1996-02-14 |
2004-09-27 |
Isis Pharmaceuticals Inc |
Sukkermodificerede gapped oligonukleotider
|
|
US6251589B1
(en)
*
|
1996-07-18 |
2001-06-26 |
Srl, Inc. |
Method for diagnosing spinocerebellar ataxia type 2 and primers therefor
|
|
WO1998018920A1
(fr)
|
1996-10-30 |
1998-05-07 |
Srl, Inc. |
Fragments d'adnc du gene responsable de l'ataxie spino-cerebelleuse de type 2
|
|
US5853995A
(en)
|
1997-01-07 |
1998-12-29 |
Research Development Foundation |
Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6
|
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO1998049345A1
(en)
|
1997-04-29 |
1998-11-05 |
Trustees Of Boston University |
Methods and compositions for targeted dna differential display
|
|
US6329501B1
(en)
*
|
1997-05-29 |
2001-12-11 |
Auburn University |
Methods and compositions for targeting compounds to muscle
|
|
US6514755B1
(en)
*
|
1998-08-18 |
2003-02-04 |
Regents Of The University Of Minnesota |
SCA7 gene and methods of use
|
|
US6280938B1
(en)
*
|
1997-08-19 |
2001-08-28 |
Regents Of The University Of Minnesota |
SCA7 gene and method of use
|
|
US6794499B2
(en)
*
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US6130207A
(en)
*
|
1997-11-05 |
2000-10-10 |
South Alabama Medical Science Foundation |
Cell-specific molecule and method for importing DNA into a nucleus
|
|
JP3012923B2
(ja)
*
|
1998-01-26 |
2000-02-28 |
新潟大学長 |
Ｃａｇリピート病の治療薬
|
|
KR100280219B1
(ko)
*
|
1998-02-26 |
2001-04-02 |
이수빈 |
삼핵산 반복 서열을 이용한 신경정신 질환의 진단 방법 및 진단 시약
|
|
US6322978B1
(en)
*
|
1998-04-20 |
2001-11-27 |
Joslin Diabetes Center, Inc. |
Repeat polymorphism in the frataxin gene and uses therefore
|
|
US6924355B2
(en)
*
|
1998-09-01 |
2005-08-02 |
Genentech, Inc. |
PRO1343 polypeptides
|
|
WO2000018895A1
(en)
*
|
1998-09-25 |
2000-04-06 |
The Children's Medical Center Corporation |
Short peptides which selectively modulate the activity of protein kinases
|
|
US6172216B1
(en)
*
|
1998-10-07 |
2001-01-09 |
Isis Pharmaceuticals Inc. |
Antisense modulation of BCL-X expression
|
|
US6399575B1
(en)
*
|
1998-11-10 |
2002-06-04 |
Auburn University |
Methods and compositions for targeting compounds to the central nervous system
|
|
US6133031A
(en)
*
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
|
US20040226056A1
(en)
*
|
1998-12-22 |
2004-11-11 |
Myriad Genetics, Incorporated |
Compositions and methods for treating neurological disorders and diseases
|
|
US20020049173A1
(en)
*
|
1999-03-26 |
2002-04-25 |
Bennett C. Frank |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
US6379698B1
(en)
*
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
|
JP2000325085A
(ja)
*
|
1999-05-21 |
2000-11-28 |
Masafumi Matsuo |
デュシェンヌ型筋ジストロフィー治療剤
|
|
US20030236214A1
(en)
*
|
1999-06-09 |
2003-12-25 |
Wolff Jon A. |
Charge reversal of polyion complexes and treatment of peripheral occlusive disease
|
|
WO2000078813A2
(en)
*
|
1999-06-18 |
2000-12-28 |
Emory University |
Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin
|
|
EP1133993A1
(en)
|
2000-03-10 |
2001-09-19 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Substances for the treatment of spinal muscular atrophy
|
|
US20020187931A1
(en)
|
2000-04-13 |
2002-12-12 |
Michael Hayden |
Modulating cell survival by modulating huntingtin function
|
|
US6653467B1
(en)
*
|
2000-04-26 |
2003-11-25 |
Jcr Pharmaceutical Co., Ltd. |
Medicament for treatment of Duchenne muscular dystrophy
|
|
WO2001083695A2
(en)
|
2000-04-28 |
2001-11-08 |
Xiao Xiao |
Dna sequences encoding dystrophin minigenes and methods of use thereof
|
|
WO2001085751A1
(en)
*
|
2000-05-09 |
2001-11-15 |
Reliable Biopharmaceutical, Inc. |
Polymeric compounds useful as prodrugs
|
|
EP1294866B1
(en)
*
|
2000-05-31 |
2010-04-14 |
Serono Genetics Institute S.A. |
Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation
|
|
US20030124523A1
(en)
*
|
2000-06-22 |
2003-07-03 |
Asselbergs Fredericus Alphonsus Maria |
Organic compounds
|
|
US6794192B2
(en)
*
|
2000-06-29 |
2004-09-21 |
Pfizer Inc. |
Target
|
|
RU2165149C1
(ru)
|
2000-07-03 |
2001-04-20 |
Шапошников Валерий Геннадьевич |
Система формования и упаковки изделий из сахарной ваты
|
|
US6727355B2
(en)
|
2000-08-25 |
2004-04-27 |
Jcr Pharmaceuticals Co., Ltd. |
Pharmaceutical composition for treatment of Duchenne muscular dystrophy
|
|
EP1191097A1
(en)
*
|
2000-09-21 |
2002-03-27 |
Leids Universitair Medisch Centrum |
Induction of exon skipping in eukaryotic cells
|
|
US6623927B1
(en)
*
|
2000-11-08 |
2003-09-23 |
Council Of Scientific And Industrial Research |
Method of detection of allelic variants of SCA2 gene
|
|
AU2002236499A1
(en)
*
|
2000-11-30 |
2002-06-11 |
Uab Research Foundation |
Receptor-mediated uptake of peptides that bind the human transferrin receptor
|
|
TWI329129B
(en)
*
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
|
US6902896B2
(en)
*
|
2001-05-11 |
2005-06-07 |
Regents Of The University Of Minnesota |
Intron associated with myotonic dystrophy type 2 and methods of use
|
|
EP1627061B1
(en)
|
2001-05-18 |
2009-08-12 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20050277133A1
(en)
*
|
2001-05-18 |
2005-12-15 |
Sirna Therapeutics, Inc. |
RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
|
|
EP1423537A4
(en)
*
|
2001-08-07 |
2006-11-29 |
Univ Delaware |
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HUNTINGTON'S DISEASE
|
|
US20060074034A1
(en)
*
|
2001-09-17 |
2006-04-06 |
Collins Douglas A |
Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
|
|
KR20030035047A
(ko)
|
2001-10-29 |
2003-05-09 |
(주)바이오코돈 |
Bmp-4 유전자 발현을 이용한 편평태선 질환의 치료 및진단방법
|
|
WO2003037172A2
(en)
*
|
2001-11-01 |
2003-05-08 |
Gpc Biotech Inc. |
Endothelial-cell binding peptides for diagnosis and therapy
|
|
US20030134790A1
(en)
*
|
2002-01-11 |
2003-07-17 |
University Of Medicine And Dentistry Of New Jersey |
Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer
|
|
WO2003069330A1
(en)
*
|
2002-02-11 |
2003-08-21 |
The Trustees Of Columbia University In The City Of New York |
System and method for identifying proteins involved in force-initiated signal transduction
|
|
US20050096284A1
(en)
*
|
2002-02-20 |
2005-05-05 |
Sirna Therapeutics, Inc. |
RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
|
|
US7771727B2
(en)
|
2002-03-01 |
2010-08-10 |
The Administrators Of The Tulane Educational Fund |
Conjugates of therapeutic or cytotoxic agents and biologically active peptides
|
|
US20040101852A1
(en)
*
|
2002-11-21 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of CGG triplet repeat binding protein 1 expression
|
|
ITRM20020253A1
(it)
|
2002-05-08 |
2003-11-10 |
Univ Roma |
Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche.
|
|
EP1380644A1
(en)
|
2002-07-08 |
2004-01-14 |
Kylix B.V. |
The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role
|
|
US7589059B2
(en)
|
2002-07-26 |
2009-09-15 |
Roche Madison Inc. |
Delivery of molecules and complexes to mammalian cells in vivo
|
|
US20050255086A1
(en)
|
2002-08-05 |
2005-11-17 |
Davidson Beverly L |
Nucleic acid silencing of Huntington's Disease gene
|
|
JP2005535318A
(ja)
|
2002-08-12 |
2005-11-24 |
ユニヴェルシテ ドゥ シェルブルック |
プレメッセンジャーｒｎａのスプライス部位選択の再プログラミング方法
|
|
GB0219143D0
(en)
|
2002-08-16 |
2002-09-25 |
Univ Leicester |
Modified tailed oligonucleotides
|
|
ES2283608T3
(es)
*
|
2002-10-23 |
2007-11-01 |
Centre For Research And Technology Hellas/Institute Of Agrobiotechnology In.A |
Secuencias peptidicas de union a la proteina prionica.
|
|
US7892793B2
(en)
|
2002-11-04 |
2011-02-22 |
University Of Massachusetts |
Allele-specific RNA interference
|
|
EP2305813A3
(en)
*
|
2002-11-14 |
2012-03-28 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
|
EP2530155B1
(en)
|
2002-11-25 |
2016-03-16 |
Masafumi Matsuo |
ENA nucleic acid drugs modifying splicing in mRNA precursor
|
|
GB0228079D0
(en)
|
2002-12-02 |
2003-01-08 |
Laxdale Ltd |
Huntington's Disease
|
|
AU2003225410A1
(en)
|
2003-03-21 |
2004-10-11 |
Academisch Ziekenhuis Leiden |
Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
|
|
AU2004239114B2
(en)
|
2003-05-14 |
2008-03-13 |
Japan Science And Technology Agency |
Inhibition of the expression of huntingtin gene
|
|
WO2004108157A2
(en)
|
2003-06-02 |
2004-12-16 |
Wyeth |
Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders
|
|
ES2302898T3
(es)
|
2003-07-11 |
2008-08-01 |
Lbr Medbiotech B.V. |
Transferencia de genes a celulas musculares mediada por el receptor de manosa-6-fosfato.
|
|
US20050054752A1
(en)
*
|
2003-09-08 |
2005-03-10 |
O'brien John P. |
Peptide-based diblock and triblock dispersants and diblock polymers
|
|
US7355018B2
(en)
*
|
2003-09-30 |
2008-04-08 |
Regeneron Pharmaceuticals, Inc. |
Modified IGF1 polypeptides with increased stability and potency
|
|
EP1680439A2
(en)
*
|
2003-10-14 |
2006-07-19 |
Kernel Biopharma Inc. |
Dual phase-pna conjugates for the delivery of pna through the blood brain barrier
|
|
US20050191636A1
(en)
|
2004-03-01 |
2005-09-01 |
Biocept, Inc. |
Detection of STRP, such as fragile X syndrome
|
|
WO2005105995A2
(en)
|
2004-04-14 |
2005-11-10 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
CA2566286A1
(en)
|
2004-05-11 |
2005-12-08 |
Rnai Co., Ltd. |
Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
|
|
ES2627917T3
(es)
|
2004-06-28 |
2017-08-01 |
The University Of Western Australia |
Oligonucleótidos no codificantes para la inducción de la omisión exónica y métodos de uso de los mismos
|
|
EP1618881A1
(en)
|
2004-07-20 |
2006-01-25 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Use of non-glucocorticoid steroids for the treatment of muscular dystrophy
|
|
ITRM20040568A1
(it)
|
2004-11-18 |
2005-02-18 |
Uni Degli Studi Di Roma Tor Vergata |
Uso della tecnica "phage display" per l'identificazione di peptidi con capacita' di legame a cellule staminali/progenitore, peptidi cosi' ottenuti e loro usi.
|
|
US20060148740A1
(en)
*
|
2005-01-05 |
2006-07-06 |
Prosensa B.V. |
Mannose-6-phosphate receptor mediated gene transfer into muscle cells
|
|
CA2596588C
(en)
|
2005-01-31 |
2017-06-27 |
University Of Iowa Research Foundation |
Nucleic acid silencing of huntington's disease gene
|
|
US20060257912A1
(en)
|
2005-05-06 |
2006-11-16 |
Medtronic, Inc. |
Methods and sequences to suppress primate huntington gene expression
|
|
CN100393320C
(zh)
*
|
2005-06-24 |
2008-06-11 |
奥林格斯技术有限公司 |
治疗肌肉萎缩的寡核苷酸药物
|
|
ATE522626T1
(de)
|
2005-06-28 |
2011-09-15 |
Medtronic Inc |
Verfahren und nukleotid-sequenzen, die bevorzugt die expression eines mutierten huntingtin-genes unterdrücken
|
|
US7906617B2
(en)
*
|
2005-12-15 |
2011-03-15 |
E. I. Du Pont De Nemours And Company |
Polyethylene binding peptides and methods of use
|
|
US20100248239A1
(en)
*
|
2009-03-24 |
2010-09-30 |
Mayo Foundation For Medical Education And Research |
Methods and materials for detecting fragile x mutations
|
|
US20110166081A1
(en)
*
|
2009-12-03 |
2011-07-07 |
University Of Iowa Research Foundation |
Alpha-dystroglycan as a Protein Therapeutic
|